T. Rowe Price Associates’s UnitedHealth UNH Stock Holding History

T. Rowe Price Associates’s Portfolio UNH Stock Details UNH Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$6.84B	Buy	21,917,663 +524,502	+2%	+$164M	0.77%	18
2025 Q1	$11.2B	Sell	21,393,161 -8,593	-0%	-$4.5M	1.38%	10
2024 Q4	$10.8B	Sell	21,401,754 -3,621,799	-14%	-$1.83B	1.25%	12
2024 Q3	$14.6B	Sell	25,023,553 -997,051	-4%	-$583M	1.68%	8
2024 Q2	$13.3B	Sell	26,020,604 -42,324	-0.2%	-$21.6M	1.59%	9
2024 Q1	$12.9B	Buy	26,062,928 +94,641	+0.4%	+$46.8M	1.58%	9
2023 Q4	$13.7B	Sell	25,968,287 -789,861	-3%	-$416M	1.84%	8
2023 Q3	$13.5B	Sell	26,758,148 -1,183,324	-4%	-$597M	1.98%	8
2023 Q2	$13.4B	Sell	27,941,472 -3,650,418	-12%	-$1.75B	1.87%	8
2023 Q1	$14.9B	Sell	31,591,890 -362,145	-1%	-$171M	2.24%	5
2022 Q4	$16.9B	Sell	31,954,035 -723,398	-2%	-$384M	2.73%	4
2022 Q3	$16.6B	Sell	32,677,433 -4,175,961	-11%	-$2.12B	2.71%	5
2022 Q2	$18.9B	Buy	36,853,394 +5,556,335	+18%	+$2.85B	2.39%	5
2022 Q1	$16B	Sell	31,297,059 -3,131,462	-9%	-$1.6B	1.61%	7
2021 Q4	$17.3B	Sell	34,428,521 -827,374	-2%	-$415M	1.56%	7
2021 Q3	$13.8B	Buy	35,255,895 +207,382	+0.6%	+$81M	1.3%	8
2021 Q2	$14B	Sell	35,048,513 -2,360,919	-6%	-$945M	1.3%	8
2021 Q1	$13.9B	Sell	37,409,432 -593,801	-2%	-$221M	1.39%	8
2020 Q4	$13.3B	Buy	38,003,233 +1,881,407	+5%	+$659M	1.37%	8
2020 Q3	$11.3B	Buy	36,121,826 +1,463,975	+4%	+$456M	1.3%	9
2020 Q2	$10.2B	Buy	34,657,851 +1,028,280	+3%	+$303M	1.29%	8
2020 Q1	$8.39B	Buy	33,629,571 +5,909,916	+21%	+$1.47B	1.33%	8
2019 Q4	$8.15B	Buy	27,719,655 +3,389,520	+14%	+$996M	1.06%	11
2019 Q3	$5.29B	Sell	24,330,135 -3,879,027	-14%	-$843M	0.75%	21
2019 Q2	$6.88B	Sell	28,209,162 -9,453,479	-25%	-$2.31B	0.97%	11
2019 Q1	$9.31B	Sell	37,662,641 -1,666,525	-4%	-$412M	1.37%	8
2018 Q4	$9.8B	Buy	39,329,166 +1,717,247	+5%	+$428M	1.66%	7
2018 Q3	$10B	Sell	37,611,919 -422,521	-1%	-$112M	1.46%	8
2018 Q2	$9.33B	Buy	38,034,440 +633,104	+2%	+$155M	1.43%	9
2018 Q1	$8B	Buy	37,401,336 +1,198,878	+3%	+$257M	1.27%	9
2017 Q4	$7.98B	Sell	36,202,458 -562,528	-2%	-$124M	1.29%	10
2017 Q3	$7.2B	Buy	36,764,986 +2,354,579	+7%	+$461M	1.23%	11
2017 Q2	$6.38B	Buy	34,410,407 +1,057,674	+3%	+$196M	1.15%	12
2017 Q1	$5.47B	Buy	33,352,733 +423,642	+1%	+$69.5M	1.03%	11
2016 Q4	$5.27B	Sell	32,929,091 -358,180	-1%	-$57.3M	1.05%	11
2016 Q3	$4.66B	Buy	33,287,271 +108,513	+0.3%	+$15.2M	0.94%	11
2016 Q2	$4.68B	Sell	33,178,758 -3,370,770	-9%	-$476M	0.99%	11
2016 Q1	$4.71B	Sell	36,549,528 -1,126,849	-3%	-$145M	1.01%	12
2015 Q4	$4.43B	Buy	37,676,377 +1,392,319	+4%	+$164M	0.93%	13
2015 Q3	$4.21B	Buy	36,284,058 +2,508,306	+7%	+$291M	0.94%	12
2015 Q2	$4.12B	Buy	33,775,752 +3,198,945	+10%	+$390M	0.85%	18
2015 Q1	$3.62B	Buy	30,576,807 +619,189	+2%	+$73.2M	0.75%	20
2014 Q4	$3.03B	Sell	29,957,618 -4,808,043	-14%	-$486M	0.64%	21
2014 Q3	$3B	Sell	34,765,661 -1,556,290	-4%	-$134M	0.65%	21
2014 Q2	$2.97B	Sell	36,321,951 -5,321,672	-13%	-$435M	0.64%	20
2014 Q1	$3.41B	Buy	41,643,623 +5,074,015	+14%	+$416M	0.77%	14
2013 Q4	$2.75B	Buy	36,569,608 +4,522,321	+14%	+$341M	0.63%	22
2013 Q3	$2.29B	Sell	32,047,287 -447,493	-1%	-$32M	0.57%	28
2013 Q2	$2.13B	Buy	+32,494,780	New	+$2.13B	0.57%	31